Books on the topic 'Schizophrenia – Epidemiology'

To see the other types of publications on this topic, follow the link: Schizophrenia – Epidemiology.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 28 books for your research on the topic 'Schizophrenia – Epidemiology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Giovanni, De Girolamo, and World Health Organization, eds. Schizophrenia. Geneva: World Health Organization, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Piccinelli, Marco. Gender differences in the epidemiology of affective disorders and schizophrenia. Geneva: WHO Division of Mental Health, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Culture and common mental disorders in Sub-Saharan Africa. East Sussex, UK: Psychology Press Ltd., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brar, Jaspreet S. Epidemiology of Schizophrenia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199331505.003.0003.

Full text
Abstract:
Epidemiology can help us understand who is at risk for developing a disorder, what may happen to them, and perhaps even why people get the disorder to begin with. In this chapter, we will review the incidence and prevalence of schizophrenia and related psychotic disorders, as well as factors affecting such rates. Risk factors for psychosis include socio-demographics (e.g., gender, age, migrant status, class), predisposing factors (e.g., season of birth, perinatal trauma), and precipitating factors (e.g., substance use, psychosocial stress). We will highlight controversial issues such as traumatic life events, prenatal infection, and cannabis use, considering how epidemiological factors can shed light on the pathogenesis of schizophrenia and related illnesses.
APA, Harvard, Vancouver, ISO, and other styles
5

(Editor), Robin M. Murray, Peter B. Jones (Editor), Ezra Susser (Editor), Jim Van Os (Editor), and Mary Cannon (Editor), eds. The Epidemiology of Schizophrenia. Cambridge University Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Murray, Robin M., Peter B. Jones, Ezra Susser, Jim Van Os, and Mary Cannon, eds. The Epidemiology of Schizophrenia. Cambridge University Press, 2002. http://dx.doi.org/10.1017/cbo9780511544118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

The epidemiology of schizophrenia. Cambridge, U.K: Cambridge University Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1931-, Tsuang Ming T., and Simpson John C, eds. Nosology, epidemiology, and genetics of schizophrenia. Amsterdam: Elsevier, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lally, John, and James H. MacCabe. Epidemiology, impact, and predictors of treatment-resistant schizophrenia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0004.

Full text
Abstract:
Treatment-resistant schizophrenia (TRS) is a disabling psychotic disorder that affects approximately 30% of those diagnosed with schizophrenia. In a significant proportion (about 70%) of patients with TRS, their illness is treatment-resistant from onset (early or primary treatment resistance), whilst, in the remainder, treatment resistance develops during the course of illness (late or secondary treatment resistance). TRS is associated with reduced quality of life and increased social and economic burden. Multiple sociodemographic, clinical, and biological risk factors have been assessed in relation to TRS, but their interpretation remains limited owing to methodological variation, lack of replicability, and a paucity of longitudinal studies. This chapter will review the epidemiology, societal and economic burden, and risk factors associated with TRS.
APA, Harvard, Vancouver, ISO, and other styles
10

Meyer, Emma, Julie Walsh-Messinger, and Dolores Malaspina. Diagnosis and Epidemiology of Psychotic Disorders. Edited by Dennis S. Charney, Eric J. Nestler, Pamela Sklar, and Joseph D. Buxbaum. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190681425.003.0012.

Full text
Abstract:
Schizophrenia spectrum disorders and affective psychoses are jointly considered in this chapter in light of the ongoing controversy concerning the diagnostic boundary between these conditions. Emil Kraepelin first separated schizophrenia (which he named dementia praecox) from manic-depressive insanity based on the deteriorating course of illness in schizophrenia, and the convention is still upheld in the DSM-5. A wealth of evidence suggests that this dichotomy does not mirror clinical reality. This chapter reviews the history of the diagnostic concepts underlying the grouping and separation of “the psychoses,” focusing on schizophrenia, schizoaffective disorder, and bipolar disorder.
APA, Harvard, Vancouver, ISO, and other styles
11

World Health Organization (WHO). Gender Differences in the Epidemiology of Affective Disorders and Schizophrenia. World Health Organization, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Medical illness and schizophrenia. Washington, DC: American Psychiatric Pub., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

1962-, Meyer Jonathan M., and Nasrallah Henry A, eds. Medical illness and schizophrenia. 2nd ed. Washington, DC: American Psychiatric Pub., 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Medical Illness and Schizophrenia (62106). American Psychiatric Publishing, Inc., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Woodberry, Kristen A., Emily Kline, and Anthony J. Giuliano. Schizophrenia Spectrum Disorders. Edited by Thomas H. Ollendick, Susan W. White, and Bradley A. White. Oxford University Press, 2018. http://dx.doi.org/10.1093/oxfordhb/9780190634841.013.17.

Full text
Abstract:
Schizophrenia spectrum disorders (SSDs) are among the most serious and complicated psychiatric disorders, particularly in children and adolescents. They have a major impact on all aspects of functioning, including family and social relationships, school, work, and self-care. While schizophrenia tends to develop in late adolescence and early adulthood, nonspecific abnormalities, prodromal symptoms, and a significant proportion of its incidence unfold before age 18. It behooves child and adolescent clinicians to be knowledgeable about and alert to the range of SSD clinical presentations. The chapter reviews the current state of the literature regarding the phenomenology, epidemiology, assessment, diagnosis, and treatment of SSD within a developmental and systems framework. Although both evidence-based and promising practices are presented, these are all too often drawn from the adult literature, underscoring the pressing need for progress in developmentally sensitive assessment and treatment research with this population. Practice implications and future directions are briefly discussed.
APA, Harvard, Vancouver, ISO, and other styles
16

Brunelle, Sarah, Ipsit V. Vahia, and Dilip V. Jeste. Late-onset schizophrenia. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0046.

Full text
Abstract:
Although schizophrenia with onset in middle or late-life is a relatively uncommon, a considerable proportion of patients do experience the first manifestations of the disease after the age of forty. The current nomenclature utilizes terminology based on age at onset: late-onset schizophrenia (LOS) for illness with onset between ages 40 and 60, and very-late-onset schizophrenia-like psychosis (VLOSLP) for onset after age 60. Recent evidence suggests more similarities than differences in epidemiology, etiology or risk factors and clinical presentation between these clinical entities, although a later onset seems to be associated with better premorbid functioning and female gender. Relatively stable cognitive deficits are observed in patients regardless of age at onset and LOS is generally not associated with a dementia, although VLOSLP are more likely to be associated with neurodegenerative processes. Antipsychotic medication is the mainstay of treatment and some psychosocial interventions may prove beneficial, but there is a lack of clinical trials focused on patients with onset in late-life. Response to treatment and outcomes tend to be better than among those with earlier onset, but special consideration should be given to biological and psychosocial factors related to the older age of patients
APA, Harvard, Vancouver, ISO, and other styles
17

Burrows, Graham. Handbook of Studies in Schizophrenia: Part One: Epidemiology, Aetiology, and Clinical Features. Elsevier Publishing Company, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Recovery from schizophrenia: An international perspective--a report from the WHO Collaborative Project, the International Study of Schizophrenia. New York, NY: Oxford University Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Kim, Hopper, ed. Recovery from schizophrenia: An international perspective : a report from the WHO collaborative project, the International Study of Schizophrenia. Oxford: Oxford University Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

(Editor), Kim Hopper, Glynn Harrison (Editor), Aleksandar Janca (Editor), and Norman Sartorius (Editor), eds. Recovery from Schizophrenia: An International Perspective: A Report from the WHO Collaborative Project, the International Study of Schizophrenia. Oxford University Press, USA, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Olfaction and the brain. Cambridge, England: Cambridge University Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Castle, David, Peter Doherty, Warrick J. Brewer, and Christos Pantelis. Olfaction and the Brain. Cambridge University Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Psychiatric disorders in the social domain: Contributions to a scientific basis for understanding and action : festschrift in honour of Professor Odd Steffen Dalgard on his 60th birthday. Oslo: Norwegian University Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Blackmore, Emma Roberston, Jessica Heron, and Ian Jones. Severe Psychopathology During Pregnancy and the Postpartum Period. Edited by Amy Wenzel. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199778072.013.15.

Full text
Abstract:
Pregnancy and childbirth can represent a challenging time for women with severe mental illness. Psychotic episodes in the perinatal period can lead to multiple adverse maternal and infant outcomes. This chapter addresses a number of key questions in relation to episodes of schizophrenia and bipolar disorder during the perinatal period. The identification and management of postpartum or puerperal psychosis is detailed, along with prognosis and risk to further pregnancies. The authors present data on epidemiology, nosology, and etiology for severe perinatal episodes. In addition, the authors discuss clinical management, and in particular, ways to identify and manage women at risk.
APA, Harvard, Vancouver, ISO, and other styles
25

North, Carol, and Sean Yutzy. Goodwin and Guze's Psychiatric Diagnosis 7th Edition. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190215460.001.0001.

Full text
Abstract:
Well known for providing a thorough yet concise view of the natural history of psychiatric disorders, this popular text has been newly updated chapter by chapter in this seventh edition. As in previous editions, each chapter systematically covers the definition, historical background, epidemiology, clinical picture, natural history, complications, family studies, differential diagnosis, and clinical management of each disorder. Terminology has been updated for consistency with changes made in DSM-5. Recent epidemiological and neurobiological findings are provided, including the long-term course of mood disorders, genetics and neuroimaging of schizophrenia and mood and other disorders, cognitive changes in relation to depression and dementia, brain stimulation techniques, outcome studies of eating disorders, and epidemiology of substance use disorders. This edition reaffirms the importance of careful psychiatric diagnosis as the essential foundation for treatment decisions. No other text provides such a lucid, well-documented and critically sound overview of the major syndromes in psychiatry. Medical students, psychiatric residents, and other students will continue to find Psychiatric Diagnosis a unique guide to the field.
APA, Harvard, Vancouver, ISO, and other styles
26

Mueser, Kim T., Douglas L. Noordsy, and Robert E. Drake. Serious Mental Illness. Edited by Kenneth J. Sher. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199381708.013.009.

Full text
Abstract:
The high comorbidity between substance use disorders and serious mental illnesses is a significant challenge to traditional treatment systems that have historically treated psychiatric and substance use disorders with different providers and agencies. Defining characteristics of serious mental illness include difficulty with work, performing in school or parenting, social difficulties, and problems caring for oneself. Common serious psychiatric disorders include schizophrenia, schizoaffective disorder, bipolar disorder, and severe major depression, posttraumatic stress disorder, and borderline personality disorder. The epidemiology of substance use disorders in serious mental illness is reviewed, including prevalence, correlates, and onset and course of the disorder. The clinical consequences of substance use disorders in this population are devastating for every possible aspect of the illness. Common factors may increase vulnerability to both substance abuse and psychiatric disorders. The principles of treating co-occurring disorders are based on modern integrated methods, as well as research on the effectiveness of integrated treatment.
APA, Harvard, Vancouver, ISO, and other styles
27

Sibley, Colin, and Phillip Baker. The Placenta and Neurodisability (Clinics in Developmental Medicine (Mac Keith Press)). MacKeith Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

1962-, Baker Philip, and Sibley Colin, eds. The placenta and neurodisability. London: Mac Keith Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography